Acorda Therapeutics Inc. | Key People and Executives
Ronald Cohen
President, Chief Executive Officer & Director
Catherine D. Strader
Independent Director
Steven M. Rauscher
Independent Director
Ian F. Smith
Independent Director
Barry E. Greene
Independent Director
Lorin Jeffry Randall
Independent Director
Peder K. Jensen
Independent Director
Sandra Panem
Independent Director
John P. Kelley
Independent Director
Ronald Cohen
President, Chief Executive Officer & Director
Burkhard Blank
Chief Medical Officer
Andrew R. Blight
Chief Scientific Officer Emeritus
Richard P. Batycky
Chief Technology Officer
Andrew Asa Hindman
Chief Business Officer
Lauren M. Sabella
Chief Commercial Officer
David Lawrence
Chief Accounting & Business Operations Officer
Felicia Vonella
Director-Investor Relations
Tierney Saccavino
Executive Vice President-Corporate Communications
Denise J. Duca
Executive Vice President-Human Resources
Jane Wasman
Secretary & President-International
Catherine D. Strader
Independent Director
Steven M. Rauscher
Independent Director
Ian F. Smith
Independent Director
Barry E. Greene
Independent Director
Lorin Jeffry Randall
Independent Director
Peder K. Jensen
Independent Director
Sandra Panem
Independent Director
John P. Kelley
Independent Director
| Address |
420 Saw Mill River Road
Ardsley New York 10502
United States
|
|
Employees
|
- |
| Website |
http://www.acorda.com |
| Updated |
07/08/2019 |
| Acorda Therapeutics, Inc. engages in the development of therapies that restore function and improve the lives of people with neurological disorders. Its two main products are Ampyra and Zanaflex Capsules. The Ampyra is an oral drug, which treats to improve walking in patients with multiple sclerosis and Zanaflex Capsules, which is a short acting drug for the management of spasticity, a symptom of many central nervous system disorders, including multiple sclerosis and spinal cord injury. |
